The role of MRgFUS in the treatment of neuropsychiatric disorders: a state of the art.

Publication date: Aug 05, 2024

Magnetic resonance-guided focused ultrasound (MRgFUS) is a contemporary non-invasive ablative procedure that utilizes high- or low-intensity ultrasound, guided and monitored by magnetic resonance imaging (MRI). While MRgFUS has been established as an effective treatment for conditions like essential tremor and tremor-dominant Parkinson’s disease, it has recently emerged as a safe and promising ablative minimally invasive procedure for the management of treatment-resistant psychiatric disorders. Indeed, despite the availability of various pharmacological and behavioral therapies, a subset of psychiatric patients remains refractory to conventional treatments. To assess the feasibility and safety of MRgFUS in psychiatric disorders, a comprehensive literature search in PubMed and Scopus databases was conducted, resulting in the inclusion of five relevant articles in this review. While data on this innovative procedure are still limited, MRgFUS demonstrates potential as a safer and less invasive surgical technique for treating these disorders. Continued research efforts and data validation are imperative to establish MRgFUS as an additional, minimally invasive procedure for treatment-resistant psychiatric patients in the near future.

Concepts Keywords
Neuropsychiatric Ablative
Parkinson Disorders
Pharmacological Guided
Safer Imaging
Tremor Invasive
Magnetic
Mrgfus
Neuropsychiatric
Procedure
Psychiatric
Resistant
Resonance
Treatment
Tremor
Ultrasound

Semantics

Type Source Name
disease MESH essential tremor
disease MESH Parkinson’s disease
disease MESH psychiatric disorders

Original Article

(Visited 4 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *